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Carotid intima media thickness (cIMT) displays prognostic value as a marker of
cardiovascular risk in dialysis patients. However, few data are available regarding the
impact of dialysis modality on cIMT. The aim of this study is to determine whether the
modality of dialysis influences cIMT values. We compared 237 peritoneal dialysis (PD)
and 451 hemodialysis (HD) patients without previous cardiovascular disease included
in NEFRONA, a prospective, observational and multicenter study. This cross sectional
study included the determination of cIMT in 6 carotid territories by arterial ultrasound.
cIMT was determined in territories without atheroma plaque and averaged. A second
analysis was performed using all territories, giving a truncated cIMT value of 1,5 mm to
territories presenting with atheroma plaque. Age and plaque presence at baseline were
the clinical variables more closely associated to cIMT in dialysis patients. The evaluation
of the impact of the modality of dialysis on cIMT showed that PD patients had lower
cIMT than HD patients, both in territories with no plaques and when using truncated
cIMT values. No differences were found between right and left sides, neither in cIMT or
truncated cIMT values. Lineal multivariate analysis adjusted by several clinical variables
showed a statistically significant association of PD with a lower cIMT (slope −0.036; SD
0.010). These results were also confirmed when truncated cIMT values were used. We
conclude that the modality of dialysis has an impact on cITM. HD patients have greater
global cIMT than PD patients, and PD is and independent factor associated with a lower
cIMT.
Keywords: intima and media thickness, dialysis, cohorts study, ultrasound, atherosclerosis
INTRODUCTION
In the last 35 years, the incidence of end-stage renal disease (ESRD) has raised dramatically. ESRD
patients have a 5-year survival probability of 50% (United States Renal Data System (USRDS), 2017;
Kramer et al., 2018) and, compared to general population, have a crude excess mortality rate of 80
to 175.(Foster et al., 2018) Main contributors to this increased mortality rates are dialysis patients,
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and among them, cardiovascular disease (CVD) accounts
for 53% of the deaths.(United States Renal Data System
(USRDS), 2017) In chronic kidney disease (CKD) patients,
atherosclerosis hallmarks are more advanced than in the general
population.(Betriu et al., 2014) This increase in atherosclerosis
burden is parallel to the degree of kidney impairment, being
higher in dialysis patients (Drueke and Massy, 2010). The
contribution of atherosclerosis to the increase in mortality
of ESRD patients has been questioned because most of
the deaths are attributed to sudden death, and related to
electrolyte imbalance. However, recent results have shown that
atherosclerosis presence is an independent factor associated with
cardiovascular events (CVE) in ESRD, and that each new arterial
territory with plaque raised a 86% the hazards of having a CVE
(Valdivielso et al., 2017).
Traditional risk factors are not useful to predict CVE on
dialysis patients. The use of the traditional algorithms in risk
stratification in CKD consistently underestimate the risk of the
CKD patients of having a CVE (Coll et al., 2010). Therefore, new
markers of cardiovascular risk in dialysis patients are needed.
Among the candidates, vascular determination of intima media
thickness of carotids (cIMT) has shown promising prognostic
value in this population (Benedetto et al., 2001). Current
knowledge about the impact of the type of dialysis on cIMT
is based on studies in small cohorts, without adjustment for
another possible confounding factors (Konings et al., 2002;
Al-Hweish et al., 2010; Shi et al., 2012). These sparse data
obtained in different cohorts, and with different methodology
and criteria, precludes knowing whether peritoneal dialysis (PD)
and hemodialysis (HD) affect cIMT differently.
There are significant differences between both modalities
of dialysis. PD patients have a potentially higher atherogenic
profile than their counterparts on HD, due to the recurrent
peritoneal loading with glucose-based dialysis solutions, and to
the continuous peritoneal leak of proteins. On the contrary, HD
patients show a worse preservation of residual kidney function,
which may contribute to inflammation, endothelial dysfunction
and vascular calcification. Moreover, PD is associated with a
stable fluid status and blood pressure pattern compared to
periodic fluctuations found in HD. Therefore, the modality of
dialysis itself could have a differential effect on cIMT determining
factors.
With the aim of shedding some light on this clinical concern,
we evaluated cIMT in a selected sub-cohort of the NEFRONA
study, in order to determine whether the modality of dialysis
influences cIMT.
MATERIALS AND METHODS
Study Design and Participants
The ethics committee of University Hospital Arnau de Vilanova
from Lleida, Spain, approved the study. All included patients
signed informed consent and the study complied with the
principles of the Declaration of Helsinki.
The NEFRONA project is a prospective, multicentre,
observational cohorts study from Spain aimed to assess the
atherosclerotic burden in CKD patients, including patients with
ESRD. The rationale and baseline description of NEFRONA
cohort have been reported in detail elsewhere. (Junyent
et al., 2010a,b) Briefly, 2445 CKD patients free from previous
CVE, aged 18 to 75 were enrolled from 81 Spanish hospitals
between October 2009 and June 2011. The exclusion criteria
were previous CVE, active infections (HIV, tuberculosis),
pregnancy, having received any organ transplantation or
having a life expectancy of less than 1 year. This study is a
cross-sectional analysis in a subcohort of the NEFRONA study,
including all the dialysis patients recruited (451 on HD and 237
on PD).
Clinical and Biochemical Data
At recruitment, patients were asked to complete a questionnaire
including family history regarding premature CVD,
clinical history (diabetes, hypertension and dyslipidaemia),
cardiovascular risk factors (such as smoking habit),
and medication use. Anthropometric data and medical
history were also obtained from all patients at the time
of recruitment. Biochemical data were obtained from a
routine blood test 3 months either before or after the
vascular ultrasound. For HD patients, blood samples
were retrieved just before the second session of the week.
High-sensitivity C reactive protein (hsCRP), 25-hydroxy-
vitamin D and 1,25-hydroxy-vitamin D were quantified
in a centralized laboratory. ABI measurements were
performed with a protocol previously described (Arroyo
et al., 2017).
Carotid Ultrasound
Patients underwent B-mode ultrasound in both carotid arteries
with the Vivid BT09 device (General Electric Instruments,
Freiburg, Germany) and a 6–13 MHz broadband linear array
probe. For imaging, patients were in supine position with
the head turned 45◦ contralateral to the side of the probe.
cIMT was measured in the last centimeter of the far wall of
the common carotid artery, the bulb section and in the first
centimeter of the internal carotid artery. Measurements were
made in plaque-free arterial segments. Atheromatous plaque,
following the recommendations of the ASE Consensus Statement
(Stein et al., 2008) and the Mannheim cIMT Consensus report
(Touboul et al., 2004), was defined by a cIMT ≥ 1.5 mm
protruding to the lumen of the imaged sections. In order to
account for the values of cIMT in territories with plaques,
a truncated cIMT value was also calculated. Truncated cIMT
calculations were made giving a cIMT value equal to 1.5 mm to
the territories with plaque. In each patient, averaged cIMT true
values or truncated values of the six territories explored were
calculated.
Ultrasound explorations were carried out by the same
itinerant team of five trained technicians. Images were analyzed
by a single reader in a blinded fashion using the EchoPAC
Dimension software (General Electric Healthcare, Harten,
Norway) in the UDETMA (Unit for the Detection and Treatment
of Atherothrombotic Diseases, Hospital Universitari Arnau
de Vilanova, Lleida, Spain). To assess the quality of the
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measurements a sample of 20 individuals was measured 3–5 times
on different days, obtaining an intraclass correlation coefficient
of 0.93.
Statistical Analysis
Quantitative variables are shown as means and standard
deviations, and its differences between groups were compared
with the Student’s t-test. Qualitative variables are summarized
as absolute and relative frequencies, and chi-squared test
(Fisher test for expected frequencies <5) was used to perform
comparisons between groups. Pearson′s correlations were used
to determine univariate relationships between cIMT values and
linear or categorical variables. Significant variables in univariate
analyses and potential confounders were used to develop
appropriate multivariate linear regression models. A forward step
procedure was used to build the multivariate model, including
the variables showing maximum contribution identifying those




A total of 451 HD and 237 PD patients were included.
Table 1 shows anthropometrical, clinical and biochemical data
comparisons between both groups. PD patients were younger,
showed increased ratios of hypertension and dyslipidemia, and
had higher systolic arterial pressure, total cholesterol, HDL and
LDL cholesterol, haematocrit, calcium and phosphate; they had
been less time on dialysis and presented with lower levels of
potassium and 25-hydroxy-vitamin D.
Variables influencing cIMT on dialysis patients.
Figure 1 shows averaged cIMT values in HD and PD patients
both in territories with no plaques (IMT) and in territories in
TABLE 1 | Demographic data.
HD (n = 451) PD (n = 237) p
Age (years) 54 (14) 51 (14) 0,004
Sex (man) 272 (60,3) 137 (57,8) 0,567
Smoker 250 (55,4) 135 (57,0) 0,381
Diabetes 107 (23,7) 47 (19,8) 0,143
Hypertension 406 (90,0) 229 (96,6) 0,001
Dyslipidemia 214 (47,5) 153 (64,6) 0,000
Plaque presence at baseline 325 (72,1) 156 (65,8) 0,054
BMI (kg/m2) 26,3 (5,0) 26,7 (4,8) 0,341
SBP (mmHg) 136 (23) 144 (24) 0,000
Time on dialysis (months) 33 (43) 20 (19) 0,000
Total cholesterol (mg/dL) 156 (39) 180 (43) 0,000
HDL cholesterol (mg/dL) 46 (16) 49 (15) 0,016
LDL cholesterol (mg/dL) 84 (32) 104 (34) 0,000
Triglycerides (mg/dL) 141 (81) 137 (66) 0,498
Glucose (mg/dL) 103 (40) 101 (37) 0,526
Hematocrite (%) 35,7 (4,3) 36,6 (4,4) 0,013
Calcium (mg/dL) 9,0 (0,7) 9,2 (0,7) 0,005
Phosphate (mg/dL) 4,8 (1,4) 5,1 (1,2) 0,008
Uric acid (mg/dL) 6,1 (1,4) 6,0 (1,2) 0,22
iPTH (pg/mL) 309 (281) 277 (255) 0,164
Sodium (mEq/L) 139 (3) 139 (3) 0,036
Potassium (mEq/L) 5,1 (0,8) 4,5 (0,6) 0,000
usCRP (mg/L) 5,6 (10,7) 6,1 (13,9) 0,624
25OH vitamin D (ng/mL) 16,4 (8,3) 12,8 (5,5) 0,000
1,25(OH)2 vitamin D (pg/mL) 8,6 (5,1) 7,7 (4,8) 0,039
Treatment with Calcium-containing P binders 186 (41,2) 119 (50,2) 0.015
Total Kt/V 1,56 (0,39) 2,52 (0,63)∗ NC
Calcium content in dialysis fluid 0.001
2.5 mEq/L 182 (41,9) 72 (35.8)
3 mEq/L 221 (50,9) NA
3,5 mEq/L 31 (7,1) 129 (64.2)
Quantitative data are shown as means (SD). Qualitative data are shown as number (%). HD, Hemodialysis; PD, Peritoneal Dialysis; BMI, Body mass index; SBP, Systolic
blood pressure; iPTH, Intact parathyroid hormone; usCRP, Ultra-sensitive C reactive protein; NA, Not available. The concentration of 3 mEq/L is not available for PD
dialysis fluid. NC, non comparable; ∗weekly Kt/V.
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FIGURE 1 | Averaged intima media thickness in carotid arterial territories depending on the dialysis modality. (A) Excluding territories with atheroma plaque;
(B) Including territories with atheroma plaque. In territories with plaque, the IMT value was truncated to 1,5 mm.
which the values of cIMT were truncated to 1.5 mm when there
was a plaque present (truncated cIMT). In both cases, PD patients
showed lower levels of cIMT than HD patients.
Among all clinical and biochemical variables considered,
the ones more closely related to cIMT were age and plaque
presence at baseline, both positively correlated (Table 2). The
other variables with positive correlation with cIMT were body
mass index (BMI), diabetes, dyslipidemia, ankle-brachial index
(ABI), potassium and glucose. The only variable with negative
correlation to cIMT was phosphate levels. We also found that
being male and in HD were correlated with a higher cIMT.
When truncated cIMT was considered, all the correlations and
significances were exacerbated except the one with phosphate,
which became non-significant.
When patients were stratified according to sex and age,
the relationship of these variables to cIMT was clearly visible,
with cIMT values increasing with age (showing a statistically
significant p-value for the trend), and more abruptly in men (both
in normal cIMT and truncated cIMT) (Figure 2). Furthermore,
the difference related to sex was maintained in all age groups.
The differences in laterality are also depicted in Figure 3.
No differences in cIMT were observed between left and right
carotids, being always higher in HD patients, regardless of the
side or whether we analyzed cIMT or truncated cIMT values.
To better assess the influence of dialysis type on cIMT,
we generated different models by means of lineal multivariate
analysis. Univariate regression assessing the effect of dialysis
type on cIMT showed a statistically significant association of
PD with a lower cIMT value. (Table 3). After adjusting by
sex and age (Model 2) the association between cIMT and
type of dialysis remained significant. This association was
maintained even after adjusting by several clinical variables
in model 3 (Diabetes, Dyslipidemia, Hypertension, BMI, ABI,
Plaque presence at baseline, Total Cholesterol, LDL Cholesterol,
Glucose, Potassium, SBP, time on dialysis) confirming an
association of PD with lower cIMT values. When truncated cIMT
values were used as the dependent variable, the effect of dialysis
type on cIMT remained. Only statistically significant variables
were maintained in the final model and shown in the table.
DISCUSSION
Our results show that on dialysis patients, cIMT values correlate
to gender, age, plaque presence at baseline, BMI and diabetes. In
non-dialysis population, previous studies also found association
of cIMT with age and sex (Dobs et al., 1999; Mutluay et al.,
2012), plaque presence (Ebrahim et al., 1999), BMI (Berni et al.,
2011) and diabetes (Brohall et al., 2006). Furthermore, our results
show that the modality of dialysis has an impact on cIMT,
even when adjusting by possible confounders. Thus, HD patients
have greater global cIMT than PD patients and being in PD is
independently associated with a lower cIMT.
Currently, studies about dialysis impact on ultrasound
measured cIMT have shown contradictory results. Despite all
studies have found higher cIMT on dialysis patients than in non-
dialysis population,(Cengiz and Dolu, 2007; Mutluay et al., 2012;
Shi et al., 2012) some of them reported higher cIMT in PD than in
HD (Ozdemir et al., 2001; Shi et al., 2012), some other did not find
significant differences on cIMT between dialysis type (Cengiz and
Dolu, 2007; Yilmaz et al., 2007; Al-Hweish et al., 2010), and some
others reported increased cIMT in HD patients (Mutluay et al.,
2012). However, it is important to remark that, in contrast to most
previous studies, the NEFRONA study excluded patients with a
previous CVE. Indeed, the only similar study that also excluded
patients that suffered a CVE (although with a quite lower number
of patients that our study) also found that HD dialysis patient
have higher cIMT (Tonbul et al., 2006).
Recently, the same NEFRONA cohort with a matched case-
control design revealed that the modality of dialysis did not
influence atheromatous vascular disease progression (assessed
as an increase in the number of atheromatous plaques) neither
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TABLE 2 | Statistically significant correlations between different parameters and cIMT values.
IMT IMT truncated
R p r p
Sex (women) −0.138 0.000 −0.137 0.000
Age 0.545 0.000 0.613 0.000
BMI 0.232 0.000 0.233 0.000
Diabetes 0.213 0.000 0.271 0.000
Dyslipidemia 0.077 0.049 0.129 0.001
ABI 0.082 0.037 0.137 0.000
Phosphate −0.086 0.027
Potassium 0.112 0.004 0.130 0.001
Glucose 0.122 0.002 0.158 0.000
Plaque presence at baseline 0.421 0.000 0.663 0.000
Type of dialysis (PD) −0.165 0.000 −0.130 0.001
FIGURE 2 | Averaged intima media thickness in carotid arterial territories stratified by age and sex. Dark bars: Males; White bars: Females. (A) Excluding territories
with atheroma plaque; (B) Including territories with atheroma plaque. In territories with plaque, the IMT value was truncated to 1,5 mm. p trend > 0,01.
did cardiovascular outcomes (Borràs Sans et al., 2017). These
results suggest that plaque and cIMT may be distinct phenotypes
rather than a manifestation of the same phenotype at different
stages or phases in the progression of atherosclerosis, being
in line with recent studies. Thus, the Northern Manhattan
Study showed that the association between elevated baseline
cIMT and the risk of new plaque formation disappeared after
adjusting for demographic and vascular risk factors (Rundek
et al., 2015). Similarly, Baroncini et al. (2015) found that increased
cIMT was related to hypertension, but plaque presence was
associated to age and dyslipidemia. Therefore, the results seems
to show that despite increased cIMT and atherosclerosis are
commonly found together, the risk factors influencing one or
another could be different and may be genetically and biologically
distinct atherosclerotic phenotypes with a heterogeneous etiology
(Spence, 2006; Della-Morte et al., 2012). Therefore, plaque may
not be a simple result of progressive intima-media thickening,
but rather a new and different event. Indeed the hypothesis that
increases in cIMT might be an adaptive event of the median layer
to increased shear stress, rather than an atherosclerotic sign, is
gaining adepts nowadays.
The possible causes of higher cIMT in HD patients than in
PD patients are unknown. However, it is well stablished that
hypertension, and particularly blood pressure variability (BPV),
plays a major role in cIMT increase (Mancia et al., 2001; García-
García et al., 2013). Short and long-term BPV are inherent to HD
treatment because of day-to-day fluctuations of volume status.
Moreover, cIMT in HD patients is more associated with long (24-
and 48-h ambulatory BP measurements) than routine dialysis
center BP measurements (Ekart et al., 2009). On the contrary,
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FIGURE 3 | Averaged intima media thickness in carotid arterial territories stratified by side. Dark bars: HD patients; White bars: PD patients. (A) Excluding territories
with atheroma plaque; (B) Including territories with atheroma plaque. In territories with plaque, the IMT value was truncated to 1,5 mm.
TABLE 3 | Lineal multivariate analysis.
Model 1 Model 2 Model 3
Slope SD p Slope SD p Slope SD p
cIMT
Type of dialysis (DP vs. HD) −0.051 0.012 0.000 −0.034 0.010 0.001 −0.033 0.010 0.001
Sex (women vs. men) −0.041 0.010 0.000 −0.036 0.010 0.000
Age (year) 0.013 0.001 0.000 0.004 0.000 0.000
Hypertension 0.041 0.017 0.016
Plaque presence at baseline 0.036 0.012 0.002
Diabetes 0.033 0.012 0.006
Truncated cIMT
Type of dialysis (DP vs. HD) −0.084 0.025 0.001 −0.041 0.019 0.033 −0.044 0.017 0.008
Sex (women vs. men) −0.076 0.019 0.000 −0.038 0.017 0.023
Age (year) 0.005 0.000 0.000 0.008 0.001 0.000
BMI 0.004 0.002 0.019
SBP (mmHg) 0.001 0.000 0.005
Plaque presence at baseline 0.269 0.021 0.000
Diabetes 0.063 0.020 0.002
Model 1 unadjusted. Model 2 adjusted for sex and age. Model 3 adjusted by sex, age, diabetes, dyslipidemia, hypertension, BMI, ABI, plaque presence at baseline, Total
Cholesterol, LDL Cholesterol, Glucose, Potassium, SBP, time on dialysis, treatment with calcium-containing phosphate binders, calcium levels in dialysis fluid.
patients in PD have more volume status stability and, accordingly,
they should present less BPV. Indeed, HD is associated with
higher systolic BPs and greater systolic loads than PD in a
study monitoring BP by continuous ambulatory blood pressure
measurements (Rodby et al., 1994). One may hypothesize that
the difference in short and long-term BPV between HD and
PD patients could explain the higher cIMT in HD patients
despite having lower casual BP measurements. In the same line
of reasoning, Günal et al. (2006) showed a decrease in cIMT with
an strict volume control in HD patients, a fact that has not been
proven to be true in PD patients (Hiramatsu et al., 2007). As a
last hypothesis for the increased cIMT in HD patients, there is
the possibility that the previously described increased levels of
pro-BNP in HD patients (Nakatani et al., 2002; Al-Hweish et al.,
2010; Sanjuan et al., 2011) could favor an increased cIMT, as it
has been published for CKD patients (DeFilippi et al., 2005; Sathi
et al., 2014); a similar effect has been described for Troponins
(Al-Hweish et al., 2010; Caliskan et al., 2012).
There is growing evidence that calcium supplements can
increase atherosclerotic CVE (Bolland et al., 2008, 2010; Li
et al., 2012; Mao et al., 2013), although some reports have
shown no statistically significant effect (Wang et al., 2010;
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Lewis et al., 2011). Therefore, there is a concern that calcium
supplements can increase atherosclerosis. Dialysis patients
can have a significant calcium intake, mainly due to the
calcium content in the dialysis fluid and in phosphate binders
administered to control hyperphosphatemia. In our study, there
was a statistically significant difference in calcium supplements,
as a higher percentage of PD patients received calcium-
containing phosphate binders and were treated with dialysis fluid
containing higher concentrations of calcium. This can be the
cause of the small but significant increase in serum calcium levels.
However, and although an inverse relationship between calcium
load and IMT is suggested in the bivariate analysis, the difference
did not reach statistical significance after adjustment for potential
confounders.
Another risk factor for atherosclerosis development is
hypertension (Hurtubise et al., 2016). Again, the percentage
of patients diagnosed with hypertension and the SBP levels
are higher in patients in PD, precisely those with lower IMT
values. The multivariate analysis demonstrated that the statistical
significance for both parameters was lost after adjustment.
Therefore, either the effect of HD on IMT is so strong that can
overcome the effect of common risk factors like hypertension,
or the increases in IMT are influenced by different risk factors
than those affecting atheroma plaque formation. Interestingly,
PD patients were more dyslipidemic and presented with higher
serum LDL-cholesterol levels than those in HD. This could be
considered not only as one more piece of evidence supporting
the hypothesis of increases in cIMT beyond an atherosclerotic
sign or a consequence of some protective effect of PD versus HD,
but also as another example of the controversial significance of
LDL-cholesterol levels in dialysis patients.
Our results also show that there are no differences between
left and right sides in cIMT neither, in PD nor HD patients.
Several reports have shown a significantly higher proportion of
cerebral ischemic events diagnosed in the left hemisphere than
in the right (Hedna et al., 2013). An explanation for the higher
incidence of events in the left hemisphere may be related to
a higher prevalence, severity, or vulnerability of atherosclerotic
disease in the left carotid artery. This is primarily attributable to
differences in flow velocity in the left carotid artery, resulting in
higher stress and intimal damage (Rodríguez Hernández et al.,
2003). However, recent reports show that the higher incidence
in left hemisphere strokes might be due to an increase in the
vulnerability of the plaques, rather than in plaque formation
(Adams et al., 2002; Selwaness et al., 2014). Thus, in our study,
no differences in cIMT were found between right and left sides,
suggesting that a systemic factor is involved in the increased
cIMT found in HD patients.
Strengths of our study are the relatively high number of
patients being, as far as we know, the biggest cohort used to
determine the effects of dialysis on cIMT. Therefore, we have
been able to adjust the models for many potential confounders.
Furthermore, and although the study is multicentric, the
execution and the analysis of the ultrasounds have been made
by a single team, avoiding the high variability associated to the
cIMT measurements. On the other hand, we have to mention
some limitations. First, the exclusion of patients that presented
CVE on the recruitment phase avoid extrapolating our results
to the entire ESRD population. Second, we only have a single
BP measurement and no fluid status data that could support the
hypothesis that higher BPV in HD patients may be related to
thicker cIMT. Third, the lack of determinations of cardiovascular
biomarkers that could affect cIMT like pro-BNP or troponins,
preclude us to determine whether the effect of dialysis modality
is related to these biomarkers or to some other factor.
In summary, we have shown that cIMT is higher in HD than in
PD and that being in PD is an independent risk factor associated
with lower cIMT in dialysis patients.
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